Transcriptional Repression of the D-Type Cyclin-dependent Kinase Inhibitor pl6 by the Retinoblastoma Susceptibility Gene Product pRb

Cancer Research

Volumn 54, Issue 23, 1994, Pages 6078-6082

  Shay, Jerry W ^b   Nichols, Michael A ^a   Xiong, Yue ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE; GENE PRODUCT;

ARTICLE; CELL CYCLE; CELL CYCLE G1 PHASE; CELL DIVISION; ENZYME ACTIVITY; FEEDBACK SYSTEM; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RETINOBLASTOMA; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION; TUMOR SUPPRESSOR GENE;

FEEDBACK; HUMAN; PROTEIN P53; PROTEIN-SERINE-THREONINE KINASES; REPRESSOR PROTEINS; RETINOBLASTOMA PROTEIN; RNA, MESSENGER; SUPPORT, NON-U.S. GOV'T; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED;

EID: 0028034775     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Norbury, C. and Nurse, P. Animal cell cycles and their control. Annu. Rev. Biochem. 61: 441-470, 1992.
2. Solomon, M.J. Activation of the various cyclin-cdc2 protein kinases. Curr. Opin. Cell Biol. 5: 180-186, 1993.
3. Xiong, Y. Zhang, H. and Beach, D. D-type cyclins associated with multiple protein kinases and the DNA replication and repair factor PCNA. Cell, 71: 505-514, 1992.
4. Zhang, H. Xiong, Y. and Beach, D. Proliferating cell nuclear antigen and p. 1 are components of multiple cell cycle kinase complexes. Mol. Biol. Cell, 4: 897-906, 1993.
5. Xiong, Y. Zhang, H. and Beach, D. Subunit rearrangement of cyclin-dependent kinases is associated with cellular transformation. Genes & Dev. 7: 1572-1583, 1993.
6. Xiong, Y. Hannon, G. Zhang, H. Casso, D. Kobayashi, R. and Beach, D. p. 1 is a universal inhibitor of the cyclin kinases. Nature (Lond.), 366: 701-704, 1993.
7. Harper, J.W. Adami, G.R. Wei, N. Keyomarsi, K. and Elledge, S.J. The p. 1 cdk-interacting protein cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell, 75: 805-816, 1993.
8. Gu, Y. Turck, C.W. and Morgan, D.O. Inhibition of CDK2 activity in vivo by an associated 20K regulatory subunit. Nature (Lond.), 366: 707-710, 1993.
9. El-Dciry, W.S. Tokino, T. Velculescu, V.E. Levy, D.B. Parsons, R. Lin, D.M. Mercer, W.E. Kinzler, K.W.V. and Vogelstein, B. WAF1, a potential mediator of p. 3 tumor suppression. Cell, 75: 817-825, 1993.
10. Serrano, M. Hannon, G.J. and Beach, D. A new regulatory motif in cell cycle control causing specific inhibition of cyclin D/CDK4. Nature (Lond.), 366: 704-707, 1993.
11. Kamb, A. Gruis, N.A. Weaver-Feldhaus, J. Liu, Q. Harshman, K. Tavitgian, S.V. Stockert, E. Day, R.S. Johnson, B.E. and Skolnick, M.H. A cell cycle regulator potentially involved in genesis of many tumor types. Science (Washington DC), 264: 436-440, 1994.
12. Nobori, T. Mlura, K. Wu, D.J. Lois, A. Takabayashi, K. and Carson, D.A. Deletion of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature (Lond.), 368: 753-756, 1994.
13. Mori, T. Miura, K. Aoki, T. Nishihira, T. Shozo, N. and Nakamura, Y. Frequent somatic mutation of the MTS1/CDK4I (multiple tumor suppressor/cyclin-dependent kinase 4 inhibitor) gene in esophageal squamous cell carcinoma. Cancer Res. 54: 3396-3397, 1994.
14. Hussussian, C.J. Struewing, J.P. Goldstein, A.M. Higgins, P.A.T. Ally, D.S. Sheahan, M.D. Clark, W.H. Tucker, M.A. and Dracopoli, N.C. Germline p. 6 mutations in familial melanoma. Nat. Genet. 8: 15-21, 1994.
15. Kamb, A. Shattuck-Eidens, D. Eeles, R. Liu, Q. Gruis, N.A. Ding, W. Hussey, C. Tran, T. Miki, Y. Weaver-Feldhaus, J. McClure, M. Aitken, J.F. Anderson, D.E. Bergman, W. Frants, R. Goldgar, D.E. Green, A. MacLennan, R. Martin, N.G. Meyer, L.J. Youl, P. Zone, J.J. Skolnick, M.H. and Cannon-Albright, L.A. Analysis of the p. 6 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus. Nat. Genet. 8: 22-26, 1994.
16. Caldas, C. Hahn, S.A. da Costa, L.T. Redston, M.S. Schutte, M. Seymour, A.B. Weinstein, C.L. Hmban, R.H. Yeo, C.J. and Kern, S.E. Frequent somatic mutations and homozygous deletions of the p. 6 (A/757) gene in pancreatic adenocarcinoma. Nat. Genet. 8: 27-32, 1994.
17. Ewen, M.E. The cell cycle and the retinoblastoma protein family. Cancer Metastasis Rev. 13: 45-66, 1994.
18. Sherr, C. The ins and outs of RB: coupling gene expression to the cell cycle clock. Trends Cell Biol. 4: 15-18, 1994.
19. Shay, J.W. Wright, W.E. Brasiskyte, D. and Van Der Haegen, B.A. E6 of human papillomavirus type 16 can overcome the Ml stage of immortalization in human mammary epithelial cells but not in human fibroblasts. Oncogene, 8: 1407-1413, 1993.
20. Li, Y. Jenkins, C.W. Nichols, M.A. and Xiong, Y. Cell cycle expression and p. 3 regulation of the cyclin-dependent kinase inhibitor p. 1. Oncogene, 9: 2261-2268, 1994.
21. Meyerson, M. and Harlow, E. Identification of G1 kinase activity for cdk6, a novel cyclin D partner. Mol. Cell Biol. 14: 2077-2086, 1994.
22. Shew, J.Y. Lin, B.T. Chen, P.L. Tseng, B.Y. Yang-Feng, T.L. and Lee, W.H. C-terminal truncation of the retinoblastoma gene product leads to functional inactivation. Proc. Natl. Acad. Sci. USA, 87: 6-10, 1990.
23. Scheffner, M. Werness, B.A. Huibregtse, J.M. Levine, A.J. and Howley, P.M. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p. 3. Cell, 63: 1129-1136, 1990.
24. Dyson, N. Howley, P.M. Munger, K-, and Harlow, E. The human papillomavirus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science (Washington DC), 243: 934-937, 1989.
25. Hinds, P.W. Mittnacht, S. Dulic, V. Arnold, A. Reed, S.I. and Weinberg, R.A. Regulation of retinoblastoma protein functions by ectopic expression of human cyclins. Cell, 70: 993-1006, 1992.
26. Nevins, J.R. E2F: a link between the Rb tumor suppressor protein and viral oncoproteins. Science (Washington DC), 258: 424-429, 1992.
27. Bates, S. Parry, D. Bonetta, L. Vousden, K. Dickson, C. and Peters, G. Absence of cyclin D/cdk complexes in cells lacking functional retinoblastoma protein. Oncogene, 9: 1633-1640, 1994.
28. Schauer, I.E. Siriwardana, S. Langan, T.A. and Sclafani, R.A. Cyclin D1 overexpression vs. retinoblastoma inactivation: implications for growth control evasion in non-small cell and small cell lung cancer. Proc. Natl. Acad. Sci. USA, 91: 7827-7831, 1994.
29. Hu, Q.J. Bautista, C. Edwards, G.M. Defeo, J.D. Jone, R.E. and Harlow, E. Antibodies specific for the human retinoblastoma protein identify a family of related polypeptides. Mol. Cell. Biol. 11: 5792-5799, 1994.